Effect of MDT-based nutritional management mode in perioperative nutritional management of gastric cancer patients

To investigate the effect of multidisciplinary team (MDT)-based nutritional management approach on the perioperative nutrition care of gastric cancer patients. A total of 120 patients who underwent radical gastrectomy for gastric cancer from November 2021 to October 2023 were retrospectively enrolled. The participants were divided into two groups: the control group (n = 60), comprising patients who underwent surgery from November 2021 to October 2022, and the observation group (n = 60), including patients who had their surgery from November 2022 to October 2023. While the control group received standard care, the observation group was administered an MDT-based nutritional management protocol in addition to the standard care. Perioperative nutritional status, postoperative gastrointestinal function parameters, gastrointestinal feeding intolerance and quality of life were compared between the two groups. Results indicated a marked improvement in the perioperative nutritional status, postoperative gastrointestinal function, and quality of life in the observation group compared to the control group (p < 0.05). Furthermore, the incidence rate of gastrointestinal feeding intolerance in the observation group was significantly lower than that in the control group, with the differences achieving statistical significance (p < 0.05). The findings suggest that the MDT nutrition management mode can improve the nutritional status of patients, promote the rehabilitation of gastrointestinal function and quality of life, and reduce the incidence of gastrointestinal feeding intolerance, which is worthy of promotion in clinical practice.

MDT; Nutritional management mode; Gastric cancer patients; Perioperative period

[1] Yao K, Uedo N, Kamada T, Hirasawa T, Nagahama T, Yoshinaga S, et al. Guidelines for endoscopic diagnosis of early gastric cancer. Digestive Endoscopy. 2020; 32: 663–698.

[2] Akbari A, Ashtari S, Tabaiean SP, Mehrdad-Majd H, Farsi F, Shojaee S, et al. Overview of epidemiological characteristics, clinical features, and risk factors of gastric cancer in Asia-Pacific region. Asia-Pacific Journal of Clinical Oncology. 2022; 18: 493–505.

[3] Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Annals of Oncology. 2022; 33: 1005–1020.

[4] Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Communications. 2021; 41: 747–795.

[5] Sugawara K, Yamashita H, Urabe M, Okumura Y, Yagi K, Aikou S, et al. Poor nutritional status and sarcopenia influences survival outcomes in gastric carcinoma patients undergoing radical surgery. European Journal of Surgical Oncology. 2020; 46: 1963–1970.

[6] Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA: A Cancer Journal for Clinicians. 2021; 71: 264–279.

[7] Gullo I, Grillo F, Mastracci L, Vanoli A, Carneiro F, Saragoni L, et al. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica. 2020; 112: 166–185.

[8] Chen ZD, Zhang PF, Xi HQ, Wei B, Chen L, Tang Y. Recent advances in the diagnosis, staging, treatment, and prognosis of advanced gastric cancer: a literature review. Frontiers in Medicine. 2021; 8: 744839.

[9] Irino T, Matsuda S, Wada N, Kawakubo H, Kitagawa Y. Essential updates 2019/2020: perioperative and surgical management of gastric cancer. Annals of Gastroenterological Surgery. 2021; 5: 162–172.

[10] Li SS, Udelsman BV, Parikh A, Klempner SJ, Clark JW, Roeland EJ, et al. Impact of postoperative complication and completion of multimodality therapy on survival in patients undergoing gastrectomy for advanced gastric cancer. Journal of the American College of Surgeons. 2020; 230: 912–924.

[11] Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. Journal of Gastric Cancer. 2023; 23: 3–106.

[12] Tokunaga M, Sato Y, Nakagawa M, Aburatani T, Matsuyama T, Nakajima Y, et al. Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives. Surgery Today. 2020; 50: 30–37.

[13] Wang HM, Wang TJ, Huang CS, Liang SY, Yu CH, Lin TR, et al. Nutritional status and related factors in patients with gastric cancer after gastrectomy: a cross-sectional study. Nutrients. 2022; 14: 2634.

[14] Kubota T, Shoda K, Konishi H, Okamoto K, Otsuji E. Nutrition update in gastric cancer surgery. Annals of Gastroenterological Surgery. 2020; 4: 360–368.

[15] Yu Z, Tu H, Qiu S, Dong X, Zhang Y, Ma C, et al. Multidisciplinary treatment for locally advanced gastric cancer: a systematic review and network meta-analysis. Journal of Minimal Access Surgery. 2023; 19: 335–347.

[16] Xiang YY, Deng CC, Liu HY, Kuo ZC, Zhang CH, He YL. The prognostic effect of multidisciplinary team intervention in patients with advanced gastric cancer. Current Oncology. 2022; 29: 1201–1212.

[17] Lu YX, Wang YJ, Xie TY, Li S, Wu D, Li XG, et al. Effects of early oral feeding after radical total gastrectomy in gastric cancer patients. World Journal of Gastroenterology. 2020; 26: 5508–5519.

[18] Rinninella E, Cintoni M, Raoul P, Pozzo C, Strippoli A, Bria E, et al. Effects of nutritional interventions on nutritional status in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN. 2020; 38: 28–42.

[19] Ida S, Kumagai K, Nunobe S. Current status of perioperative nutritional intervention and exercise in gastric cancer surgery: a review. Annals of Gastroenterological Surgery. 2022; 6: 197–203.

[20] Mizukami T, Piao Y. Role of nutritional care and general guidance for patients with advanced or metastatic gastric cancer. Future Oncology. 2021; 17: 3101–3109.

[21] Chen Y, Xiang J, Liu D, Xiao J, Xiong F, Wei K, et al. Multidisciplinary team consultation for resectable Gastric Cancer: a propensity score matching analysis. Journal of Cancer. 2021; 12: 1907–1914.

[22] Uehara H, Ota M, Yamamoto M, Nakanoko T, Shin Y, Shiokawa K, et al. Prognostic significance of preoperative nutritional assessment in elderly patients who underwent laparoscopic gastrectomy for stage I–III gastric cancer. Anticancer Research. 2023; 43: 893–901.

[23] Matsui R, Inaki N, Tsuji T. Impact of preoperative nutritional assessment on other-cause survival after gastrectomy in patients with gastric cancer. Nutrients. 2023; 15: 3182.

[24] Wang L, Miao Y, Chen T, Sun D, Ge S, Zuo L, et al. Value of the preoperative prognostic nutritional index for the evaluation of patient prognosis after radical gastrectomy. Molecular and Clinical Oncology. 2020; 12: 196–201.

[25] Hirahara N, Tajima Y, Fujii Y, Kaji S, Kawabata Y, Hyakudomi R, et al. Prediction of postoperative complications and survival after laparoscopic gastrectomy using preoperative geriatric nutritional risk index in elderly gastric cancer patients. Surgical Endoscopy. 2021; 35: 1202–1209.

[26] Wada Y, Nishi M, Yoshikawa K, Takasu C, Tokunaga T, Nakao T, et al. Preoperative nutrition and exercise intervention in frailty patients with gastric cancer undergoing gastrectomy. International Journal of Clinical Oncology. 2022; 27: 1421–1427.

[27] Nakada K, Kimura A, Yoshida K, Futawatari N, Misawa K, Aridome K, et al. Effect of four main gastrectomy procedures for proximal gastric cancer on patient quality of life: a nationwide multi-institutional study. Journal of Gastric Cancer. 2023; 23: 275.

[28] Kinami S, Nakamura N, Zhiyong J, Miyata T, Fujita H, Takamura H, et al. Severity of postgastrectomy syndrome and quality of life after advanced gastric cancer radical gastrectomy. Molecular and Clinical Oncology. 2020; 13: 133–140.